Severe Asthma

🌟 School-based health centres (SBHCs) are improving healthcare for underserved youth across the US! These centres provide vital services, from preventive care to chronic disease management, right where students need them most - in schools. 📚🏥 SBHCs improve academic performance, reduce absenteeism, and enhance overall student well-being. Let's support these essential centres and ensure every child has access to quality healthcare. 🌟 #SyenzaNews #SBHC #ChronicDiseaseManagement #HealthEquity #PreventiveCare

🌟 New Insights on Integrated Care for Children 🌟 This recent study evaluates the cost-effectiveness of the Children and Young People's Health Partnership (CYPHP) model for chronic conditions like asthma, eczema, and constipation. Discover how integrated care impacts health outcomes and societal costs. 📊 #SyenzaNews #ChronicConditions #IntegratedCare #Paediatrics #CostEffectiveness #HealthEconomics 👉

🌬️ Breathe easier with new COPD treatment insights! Discover how #Ensifentrine could improve life for millions. 🏥💡 Read our latest article on #COPDmanagement and learn about the potential of this innovative therapy as well as its cost-effectiveness. #RespiratoryHealth #PatientCare #HealthcareInnovation

📚 New research findings alert! 🚨 A recent study shows that increasing coverage of maternal, child and inpatient services is associated with reduced poverty in low and middle-income countries. 💡 This supports pro-poor approaches towards Universal Health Coverage. 🌍 Let's work together to ensure #HealthForAll and #EndPoverty. Read more here 📖 #UHC #GlobalHealth #HealthEquity

🚀 Great news for COPD patients! NICE has recommended two digital technologies, myCOPD and SPACE for COPD, to deliver pulmonary rehabilitation. 🏥 These platforms offer personalised exercise programmes and educational sessions, empowering patients to manage their condition at their convenience. 💻 Let's embrace this digital revolution in healthcare! #COPD #DigitalHealthcare #PulmonaryRehabilitation

The Asthma Challenge The chronic disease known as asthma, which is characterised by inflammation of the airways, affects between 10 and 12 percent of children around the world and a sizeable percentage of adults. It is the ailment that affects children the most frequently and is a big contributor to the burden of health problems all around the world. In order to alleviate the enormous physical and financial burden that asthma exacerbations impose, it is essential to diagnose the condition […]

The escalating prevalence of chronic diseases coupled with an ageing population is leading to a significant surge in demand for continuous home and institutional care. With professional resources in Québec becoming increasingly limited, virtual care tools have emerged as a crucial solution to ensure access to care and services. The COVID-19 pandemic has accelerated the use of virtual care tools, promoting continuity of care when in-person visits became risky or impossible. These tools, ranging from telemonitoring to teleconsultation, are becoming […]

In the face of an ageing population, increased chronic diseases, and limited professional resources, Quebec is turning to virtual care tools to meet the growing demand for home and institutional care. This shift has been further accelerated by the COVID-19 pandemic, which has highlighted the potential of virtual care in specialty medicine. The Quebec Ministry of Health and Social Services (MSSS) has tasked the National Institute for Excellence in Health and Social Services (INESSS) with providing a state-of-knowledge report to […]

Tezepelumab as an add-on maintenance treatment is recommended as an option for severe asthma in people 12 years and over, when treatment with high-dose inhaled corticosteroids plus another maintenance treatment has failed. It is recommended only if people: Have had 3 or more exacerbations in the previous year, or Are having maintenance oral corticosteroids. Tezepelumab should be discontinued if the rate of severe asthma exacerbations, or the maintenance oral corticosteroid dose, have not been reduced by at least 50% at […]